Article
Molecular Characterization of the Highest Risk Adult Patients with Acute Myeloid Leukemia (AML) through Multi-omics Clustering
2021-07-08
Abstract excerpt
<h4>Background: </h4> Acute myeloid leukemia (AML) is a clinically heterogeneous group of diseases with poor outcomes that are partly due to its complex and poorly understood heterogeneity. <h4>Methods: </h4> Here, we use a multi-omics approach to identify a molecular subgroup with the worst response to chemotherapy, and to identify promising drug targets specifically for this AML subgroup. <h4>Results: </h4> Mult...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 917c77f6-714b-5472-9eb8-f1f6348e6924
- DOI
- 10.21203/rs.3.rs-138491/v2
